Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Barito Pacific Tbk (BRPT.JK)
Jakarta, ID
PT Barito Pacific Tbk, through its subsidiaries, is primarily engaged in petrochemical production. Its business activities are segmented across Petrochemicals, Property (which covers Building and Hotel Management), Energy and Resources, and other ventures. The company's petrochemical offerings include olefins such as ethylene, propylene, py-gas, and mixed C4, alongside polyolefins like polyethylene and polypropylene. It also manufactures styrene monomer, a foundational material for various downstream products including polystyrene (PS), expanded PS, styrene acrylonitrile, acrylonitrile butadiene styrene, styrene butadiene rubber, styrene butadiene latex, and unsaturated polyester resins. Additionally, it produces polybutadiene rubber and solution styrene butadiene rubber, key components for tire manufacturing. Beyond chemicals, Barito Pacific operates in the geothermal energy sector. Its property division undertakes real estate management, develops industrial and commercial properties, commercial complexes, office spaces, and standard factory buildings, and owns and manages hotels. The company's diverse portfolio further includes logistics and adhesive production. Established in 1979 and headquartered in Jakarta, Indonesia, the company was formerly known as PT Barito Pacific Timber Tbk before changing its name in 2007.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.39% | -7.23% | +13.84% | -0.91% | -42.33% | -31.66% | +154.97% | +171.24% | +152.03% | +4,468.32% | +38,484.07% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals: +4.0%+219.7% ★ Q1'26: +229.6% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+766.7% ★ Q1'26: +400.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+21.2% ★ Q1'26: -13.1% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+26.2% ★ Q1'26: +19.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+18.9% ★ Q1'26: +14.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.1% ★ Q1'26: -3.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×3.51× Q1'26: 3.49× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.45B
est: 2.38B (+3.0%)
|
3.07B
est: 3.07B (+0.0%)
|
2.40B
est: 2.35B (+2.0%)
|
2.33B
est: 2.24B (+4.0%)
|
3.16B
est: 3.03B (+4.0%)
|
2.96B
est: 3.85B (-23.0%)
|
2.76B
est: 155.3K (+1,777,737.2%)
|
2.39B
est: 2.62B (-8.8%)
|
7.63B
est: 8.50B (-10.2%)
|
17.82B
14.77B – 20.73B
+109.6% YoY
|
18.08B
10.75B – 25.07B
+1.5% YoY
|
15.82B
13.11B – 18.41B
-12.5% YoY
|
| EBITDA |
720.72M
est: 444.02M (+62.3%)
|
626.17M
est: 573.32M (+9.2%)
|
423.59M
est: 440.13M (-3.8%)
|
433.00M
est: 419.49M (+3.2%)
|
650.21M
est: 566.97M (+14.7%)
|
342.00M
est: 719.28M (-52.5%)
|
532.61M
est: 32.7K (+1,631,068.1%)
|
560.21M
est: 550.16M (+1.8%)
|
2.31B
est: 1.79B (+29.0%)
|
3.75B
3.11B – 4.36B
+109.6% YoY
|
3.80B
2.26B – 5.27B
+1.5% YoY
|
3.33B
2.76B – 3.87B
-12.5% YoY
|
| EBIT |
744.34M
est: 409.89M (+81.6%)
|
662.20M
est: 529.25M (+25.1%)
|
425.33M
est: 406.30M (+4.7%)
|
425.32M
est: 387.24M (+9.8%)
|
623.50M
est: 523.39M (+19.1%)
|
347.28M
est: 663.99M (-47.7%)
|
350.07M
est: 29.2K (+1,199,009.4%)
|
552.92M
est: 491.89M (+12.4%)
|
2.00B
est: 1.60B (+25.0%)
|
3.35B
2.78B – 3.90B
+109.6% YoY
|
3.40B
2.02B – 4.71B
+1.5% YoY
|
2.98B
2.47B – 3.46B
-12.5% YoY
|
| Net Income |
118.12M
est: 187.82M (-37.1%)
|
72.23M
est: 132.64M (-45.5%)
|
137.38M
|
141.38M
est: 79.40M (+78.1%)
|
296.01M
est: 108.00M (+174.1%)
|
32.21M
est: 84.52M (-61.9%)
|
26.12M
est: 1.8K (+1,416,169.0%)
|
56.48M
est: 40.08M (+40.9%)
|
489.81M
est: 396.56M (+23.5%)
|
273.55M
213.72M – 333.38M
-31.0% YoY
|
313.49M
280.07M – 346.90M
+14.6% YoY
|
402.53M
314.49M – 490.57M
+28.4% YoY
|
| SGA |
55.72M
est: 83.30M (-33.1%)
|
74.23M
est: 107.55M (-31.0%)
|
77.27M
est: 82.57M (-6.4%)
|
89.39M
est: 78.69M (+13.6%)
|
91.81M
est: 106.36M (-13.7%)
|
98.96M
est: 134.94M (-26.7%)
|
99.64M
est: 5.4K (+1,860,516.2%)
|
91.76M
est: 90.24M (+1.7%)
|
270.39M
est: 293.27M (-7.8%)
|
614.81M
509.39M – 715.16M
+109.6% YoY
|
623.75M
370.67M – 864.69M
+1.5% YoY
|
545.87M
452.27M – 634.97M
-12.5% YoY
|
| EPS |
0.00
est: 0.00 (+9.8%)
|
0.00
est: 0.00 (-36.4%)
|
0.00
|
0.00
est: 0.00 (+77.1%)
|
0.00
est: 0.00 (+177.8%)
|
0.00
est: 0.00 (-66.7%)
|
0.00
est: 0.00 (+1,527,239.4%)
|
0.00
est: 0.00 (+39.5%)
|
0.01
est: 0.00 (+22.9%)
|
0.00
0.00 – 0.00
-30.6% YoY
|
0.00
0.00 – 0.00
+10.5% YoY
|
0.00
0.00 – 0.01
+33.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B- | 2/5 | 1/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Agus Salim Pangestu | President Director | — | male |
| David Kosasih | Finance and Accounting Director, Secretary & Director | — | male |
| Rudy Suparman | Vice President Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BRPT.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
